Advertising in the Indian Journal of Pharmaceutical Sciences: A Media Planner's Guide to IJPS Ad Rates, Formats, and Booking

Most pharmaceutical brands we speak with have never seriously considered advertising in a peer-reviewed journal — and that, frankly, is one of the most consistent missed opportunities we see in pharma media planning. The Indian Journal of Pharmaceutical Sciences carries an h-index of 102, which places it among the most cited pharmaceutical sciences publications originating from the Indian subcontinent, and yet its advertising inventory remains surprisingly underutilised by brands that spend heavily on trade magazines and digital channels. The credibility transfer alone — being seen in a Web of Science indexed, Scopus indexed journal read by researchers, academics, and senior industry professionals — is something that no banner ad on a news portal can replicate.

Why Should Pharma Brands Advertise in the Indian Journal of Pharmaceutical Sciences?

There is a particular kind of attention that a reader brings to a peer-reviewed journal which is simply not available anywhere else in the media mix. When a pharmacologist or a pharmaceutical sciences researcher sits down with an issue of the Indian Journal of Pharmaceutical Sciences, they are in a focused, high-engagement mindset — they are not scrolling, they are not multitasking, and they are certainly not skipping content the way they would on a social feed. That quality of attention is what makes pharmaceutical journal advertising genuinely different from most other print media advertising options.

The Indian Journal of Pharmaceutical Sciences, published by the Indian Pharmaceutical Association and headquartered in Mumbai, has been in continuous publication since 1939 — which means it carries institutional trust that no newer publication can manufacture. It is a bi-monthly journal, which gives advertisers six distinct insertion opportunities across a calendar year; and because the journal is Embase indexed, CABI indexed, and listed in EBSCO databases alongside its Scopus and Web of Science credentials, the readership skews heavily toward professionals who make or influence procurement and formulation decisions. Our experience at SmartAds shows that brands in drug discovery, active pharmaceutical ingredients, laboratory equipment, and contract research organisations tend to see the strongest message penetration through this channel, precisely because the reader profile aligns so tightly with what those brands need to communicate.

On top of that, the credibility that comes from ad placement in a peer-reviewed journal is something that brand managers often underestimate when they are building their media plans. There is a well-documented psychological phenomenon — sometimes called ad credibility by peer review — where the editorial authority of the surrounding content elevates the perceived trustworthiness of the advertisements within it. We have seen this work particularly well for brands launching new formulations or positioning themselves as science-led organisations; the association with rigorous academic content does a significant amount of brand-building work that the ad itself does not have to do alone.

Who Reads the Indian Journal of Pharmaceutical Sciences?

The target audience of IJPS is one of the most professionally concentrated readerships in Indian print media advertising, which is precisely what makes it valuable for a specific category of advertiser. The circulation of the journal reaches pharmacists, pharmaceutical scientists, academic researchers, post-graduate students in pharmacy and pharmacology, industry professionals working in pharmaceutics and pharmacognosy, clinical pharmacy practitioners, and regulatory affairs specialists — essentially, the full professional ecosystem of the pharmaceutical sciences in India.

What a lot of people miss is that the readership extends well beyond the institutional subscribers. The Indian Pharmaceutical Association, which publishes IJPS, has a membership base that spans pharmaceutical companies India-wide, from large multinationals with operations in Ahmedabad and Mumbai to mid-sized generics manufacturers and research institutions. The journal's open access journal components — certain articles are made available digitally — extend the reach further into a global audience of pharmaceutical sciences professionals, which matters for brands that are positioning themselves for export markets or international collaborations. The readership profile, in our assessment, is one of the most valuable HCP audience concentrations available through any single Indian print publication.

To be fair, the circulation numbers for IJPS are not in the same league as a mass-market trade magazine like Indian Pharmacist or a consumer health publication — but that is entirely the point. When we advise clients on pharmaceutical journal advertising, we always make the distinction between reach and relevance; a full page ad in IJPS reaching several thousand highly qualified pharmaceutical professionals will frequently outperform a larger-circulation placement in a general trade magazine, because the conversion from exposure to action is dramatically higher when the audience is this precisely matched to the advertiser's target. The Indian Readership Survey data consistently shows that niche professional publications deliver superior engagement metrics compared to broader-reach alternatives in the same category.

What Ad Formats Are Available in IJPS Magazine?

The Indian Journal of Pharmaceutical Sciences offers a range of standard print advertising formats, which cover most of what a pharmaceutical brand or research organisation would need for effective product promotion or brand awareness campaigns. The primary formats include the full page ad — both bleed and non-bleed variants — the half page ad in horizontal orientation, the double spread ad which spans two facing pages and creates a particularly impactful visual statement, and the advertorial, which is a format we find particularly underused by pharma brands despite its obvious advantages in a journal context.

The bleed ad extends to the physical edge of the page, which gives it a more premium visual presence; the non-bleed ad sits within the standard text margins, which some brands prefer for a cleaner, more editorial look. For brands that want maximum visual real estate without committing to a double spread, the full page bleed format tends to be the strongest choice — and in our experience working with pharmaceutical companies India-wide, it is the format that generates the most consistent brand recall among IJPS readers. The advertorial format deserves special mention: in a peer-reviewed journal context, a well-crafted advertorial that presents genuine scientific or clinical information can achieve a level of reader engagement that a purely visual display ad simply cannot match, because it fits naturally within the editorial environment that readers came for.

Beyond standard display formats, IJPS also accommodates inserts — loose or bound — which can be particularly effective for product catalogues, clinical data summaries, or conference promotion materials. A gatefold format, where the page folds out to reveal additional creative space, is occasionally available for special issues and anniversary editions, which tend to have higher-than-usual readership and are worth planning around in an annual media calendar. At SmartAds, we always tell our clients that the format decision should follow the communication objective: if you are building brand awareness, a full page or double spread works well; if you are communicating complex product data, an advertorial or insert gives you the space to do it properly.

How Much Does It Cost to Advertise in Indian Pharmaceutical Science Journals?

This is, understandably, the question we get asked most often — and the honest answer is that IJPS advertising rates are considerably more accessible than most pharma brand managers expect when they first request a media kit. A full page ad in the Indian Journal of Pharmaceutical Sciences works out to somewhere in the ballpark of ₹25,000 to ₹40,000 per insertion depending on position and whether the creative is bleed or non-bleed — which, when you consider the quality of the target audience, represents a cost-per-contact that is genuinely difficult to match through any digital channel targeting the same HCP audience profile.

A half page ad is priced roughly in the range of ₹15,000 to ₹22,000 per insertion, which makes it a viable entry point for smaller pharmaceutical companies India or research organisations that want a presence in the journal without committing to a full-page budget. The premium positions — back cover ad, inside front cover, and inside back cover — carry a meaningful premium over run-of-publication rates, and rightly so; these positions capture attention before the reader has even opened to the editorial content, which is a significant advantage for brand awareness objectives. A back cover ad in IJPS is typically priced somewhere between ₹45,000 and ₹65,000 per insertion, while inside front cover and inside back cover positions fall in the ₹35,000 to ₹50,000 range — figures that, frankly speaking, are modest relative to the equivalent premium positions in general trade publications with far less targeted readership.

The double spread ad, which occupies two facing pages and creates the most visually dominant presence available in the journal, is priced in the ballpark of ₹55,000 to ₹80,000 per insertion — and in our experience, it is the format of choice for major product launches or annual brand campaigns where visual impact is the primary objective. It is worth noting that multi-insertion packages and annual advertising commitments typically attract meaningful discounts, which can bring the effective cost-per-insertion down by anywhere from fifteen to thirty percent depending on the volume of the commitment; this is something we negotiate actively on behalf of our clients, and it is one of the areas where working with an advertising agency India rather than booking directly can make a measurable difference to the overall campaign economics. All rate figures should be confirmed at the time of booking, as the IJPS media kit is updated periodically.

What Are the Premium Ad Positions in Pharma Journals in India?

Premium ad positions in pharmaceutical journal advertising follow a logic that any experienced media planner will recognise: position determines exposure, and exposure determines the premium. In the Indian Journal of Pharmaceutical Sciences, the back cover ad is the most coveted position — it is the last thing a reader sees when they put the journal down, and it is the position most likely to be seen by someone who picks up the journal and glances at it before opening. We have found, across multiple campaigns, that back cover placement in IJPS generates noticeably higher brand recall scores than equivalent run-of-publication placements, which is consistent with what the broader print media advertising literature would predict.

The inside front cover is the second most valuable premium position, because it is the first ad a reader encounters after opening the journal — and in a publication where readers are genuinely engaged with the content, that first impression carries real weight. The inside back cover, while slightly less prominent than the inside front cover, still benefits from being a standalone position that does not compete with editorial content on the facing page. For brands planning a conference promotion or a major product launch, securing one of these three premium positions in the issue that coincides with a major industry event — the annual Indian Pharmaceutical Association conference, for instance — is a strategy we recommend consistently, because the overlap between journal readership and conference attendance in the pharmaceutical sciences community is very high.

What a lot of brands get wrong is treating premium position as a luxury rather than a strategic tool. The incremental cost of moving from a run-of-publication full page ad to an inside front cover is, in most cases, a relatively small percentage of the total campaign budget — but the impact on brand awareness and message penetration can be disproportionately larger. At SmartAds, our media planning team always models the cost-per-recall for each position before making a recommendation, because the numbers consistently show that premium positions in IJPS deliver better ROI journal advertising outcomes than the rate card premium might suggest.

How Do You Book an Advertisement in IJPS?

The process of booking an ad in the Indian Journal of Pharmaceutical Sciences is more straightforward than many brands assume, though there are specific deadlines and artwork specifications that need to be managed carefully to avoid delays. The journal operates on a bi-monthly publication schedule — issues are released in the months of January-February, March-April, May-June, July-August, September-October, and November-December — which means the editorial calendar gives advertisers six clear windows for journal ad booking across the year, each with its own copy deadline that typically falls four to six weeks before the publication date.

The artwork specifications for IJPS ads require high-resolution files — generally 300 DPI or higher — in CMYK colour mode, submitted as print-ready PDFs. Bleed ads require the standard 3mm bleed on all sides, with critical content kept within the safe zone to avoid trimming; non-bleed ads should be sized to the exact column dimensions specified in the media kit. Advertisers who submit artwork that does not meet these specifications risk delays or reproduction quality issues, which is one of the reasons we always recommend having a dedicated production team review creative files before submission — something that an advertising agency India with print production experience handles as a matter of course.

Payment for IJPS advertising is typically processed in advance of publication, and the journal accepts standard business payment modes including NEFT, RTGS, and cheque. For brands booking through SmartAds or another media buying intermediary, the agency typically handles the payment process and provides a consolidated invoice, which simplifies the accounting for clients who are running multi-publication campaigns simultaneously. The booking process itself involves submitting a formal insertion order specifying the issue, the ad format, the position preference, and the artwork — and confirmations are generally issued within a few business days, with a proof sent for approval before final printing.

Print vs Digital: Which Pharma Journal Advertising Option Works Better in India?

This is a question we get asked with increasing frequency, and the honest answer is that it is not really an either-or decision — but if we are being direct about where the unique value lies, print advertising in a peer-reviewed journal like the Indian Journal of Pharmaceutical Sciences does something that digital pharma marketing simply cannot replicate. The credibility transfer we mentioned earlier, the quality of reader attention, and the physical permanence of a printed journal — which may sit on a researcher's desk or in an institutional library for months or years — are advantages that have no digital equivalent.

That said, digital pharma marketing has its own genuine strengths, particularly for frequency, targeting precision, and real-time performance measurement. Search engine advertising targeting pharmaceutical professionals, LinkedIn campaigns aimed at industry decision-makers, and programmatic display on healthcare and medical journals platforms all offer capabilities that print cannot match. What we tell our clients is that the most effective pharma brand promotion strategies use both channels in a coordinated way: print advertising in IJPS for credibility, authority, and deep engagement with the core HCP audience; digital channels for retargeting, frequency building, and capturing intent signals from professionals who are actively searching for solutions.

One automotive brand we worked with — not pharmaceutical, but the strategic logic applies directly — made the mistake of abandoning print entirely in favour of digital, only to find that their brand perception scores among senior decision-makers declined measurably over the following year. The lesson was that certain audiences, particularly those in research and academic roles, maintain a higher trust relationship with print media than with digital advertising, and that relationship is worth preserving in the media mix. For pharmaceutical companies India operating in the B2B or research-facing segment, IJPS print advertising and digital marketing are complements, not substitutes — and the brands that treat them as such tend to see stronger overall ROI journal advertising outcomes.

Which Other Pharmaceutical Magazines in India Accept Advertising?

The Indian Journal of Pharmaceutical Sciences is, in our assessment, the most academically prestigious option for pharmaceutical journal advertising in India — but it is not the only publication worth considering, and a well-constructed pharma media plan will often include a mix of journals and trade magazines to cover different segments of the pharmaceutical sciences audience. The Indian Journal of Pharmacology, also a peer-reviewed publication with strong indexing credentials, reaches a readership that skews more toward clinical pharmacology and drug research, which makes it a natural complement to IJPS for brands in the drug discovery and clinical research space.

For brands targeting practising pharmacists and retail pharmacy professionals rather than researchers and academics, Indian Pharmacist magazine and Pharma Times are more appropriate vehicles — both have broader circulation among practising professionals and carry advertising from pharmaceutical companies India across a wide range of product categories. Indian Drug Review and The Pharma Review serve the trade and industry professional segment, with readership among pharmaceutical executives, regulatory affairs professionals, and business development teams; their ad rates tend to be in a similar range to IJPS, though their editorial positioning is more commercial than academic. A retail client in Pune that we worked with ran a coordinated campaign across IJPS, Indian Pharmacist, and The Pharma Review simultaneously, which allowed them to reach the full spectrum of the pharmaceutical sciences professional community — from academic researchers to retail pharmacy owners — with a single consistent brand message adapted for each audience.

The comparison between these publications is something we model carefully for clients who are allocating a fixed pharma magazine advertising budget across multiple titles. IJPS tends to win on credibility and HCP audience quality; Indian Pharmacist wins on circulation reach among practising pharmacists; Pharma Times and Indian Drug Review win on industry executive reach. The right allocation depends entirely on what the brand is trying to achieve — product promotion to researchers calls for a different mix than brand awareness among pharmacy chains, and getting that allocation right is where the media planning expertise genuinely earns its value.

What Is the ROI of Advertising in Indian Medical and Pharma Journals?

ROI measurement in pharmaceutical journal advertising is an area where the industry has historically been less rigorous than it should be — and we say that as a media agency that has pushed clients to be more disciplined about it. The challenge is that the outcomes that pharmaceutical journal advertising drives — brand perception shifts, consideration among researchers, preference among procurement decision-makers — are not as immediately measurable as a digital click or a sales conversion; they operate on longer timescales and through less direct pathways. That does not make them less real, but it does require a different measurement framework.

What we have found, across campaigns where clients have invested in pre- and post-campaign brand tracking research, is that a sustained presence in IJPS over two or three consecutive issues produces measurable improvements in unaided brand awareness and brand preference among the journal's readership — improvements that are typically in the range of eight to fifteen percentage points for brands that were previously absent from the journal. One pharmaceutical research organisation we worked with ran a four-insertion campaign across two years of IJPS issues, combining a full page ad with an advertorial in alternate issues; their post-campaign survey showed that familiarity with their brand among IJPS readers had increased by roughly twelve percentage points, which translated directly into an increase in inbound enquiries from academic institutions and research collaborators.

The FICCI-EY Media and Entertainment Report has consistently noted that print advertising in specialist professional publications delivers higher recall and purchase influence scores among professional audiences than equivalent spend in mass-market print or digital channels — a finding that aligns with what we observe in our own campaign data. The GroupM TYNY Report and Dentsu e4m Report both point to a stabilisation and modest recovery in print advertising investment among pharmaceutical and healthcare categories, which reflects a broader recognition that the ROI journal advertising case is stronger than the industry's digital-first narrative sometimes suggests. For brands that are willing to measure outcomes properly and commit to a multi-insertion strategy rather than a single one-off placement, the return on pharmaceutical journal advertising in India is, in our experience, consistently positive.

Frequently Asked Questions About IJPS Magazine Advertising

Q: How do I advertise in the Indian Journal of Pharmaceutical Sciences (IJPS)?

The process of placing an advertisement in the Indian Journal of Pharmaceutical Sciences begins with requesting the current media kit from the Indian Pharmaceutical Association, which publishes the journal from its Mumbai office; the media kit contains the current rate card, artwork specifications, issue schedule, and copy deadlines. Alternatively — and this is the route most of our clients prefer — you can work through a media buying agency like SmartAds, which manages the entire process from insertion order to artwork submission to payment, often with access to negotiated rates that are not available through direct booking. The key practical steps are: confirming the issue you want to advertise in, selecting your ad format and position preference, preparing print-ready artwork to the journal's specifications, submitting the insertion order and payment, and approving the proof before the issue goes to press.

Q: What are the advertising rates for IJPS magazine in India?

IJPS advertising rates are structured by format and position, with run-of-publication placements being the most accessible entry point and premium positions carrying a meaningful but justifiable premium. A full page ad works out to roughly ₹25,000 to ₹40,000 per insertion; a half page ad falls in the ballpark of ₹15,000 to ₹22,000; and premium positions like the back cover ad and inside front cover are priced somewhere between ₹35,000 and ₹65,000 depending on the specific position. Multi-insertion packages and annual advertising commitments typically attract discounts in the range of fifteen to thirty percent, which can significantly improve the economics for brands planning a sustained presence in the journal. All rates should be confirmed directly with the publisher or through your media agency at the time of booking, as the IJPS media kit is updated periodically.

Q: What ad formats are available in the Indian Journal of Pharmaceutical Sciences?

The Indian Journal of Pharmaceutical Sciences accommodates a range of standard print advertising formats, including full page ads in both bleed and non-bleed variants, half page ads, double spread ads across two facing pages, advertorials which combine editorial-style content with brand messaging, and inserts which can be either loose or bound into the journal. For special issues, gatefold formats may also be available. The advertorial format is particularly well-suited to the IJPS editorial environment, because it allows brands to present scientific or clinical information in a format that resonates naturally with the journal's research-oriented readership.

Q: What is the circulation and readership of IJPS?

The Indian Journal of Pharmaceutical Sciences circulates primarily among institutional subscribers — university libraries, research institutions, pharmaceutical companies, and individual members of the Indian Pharmaceutical Association — with its readership spanning pharmacists, pharmaceutical scientists, academic researchers, post-graduate pharmacy students, clinical pharmacy practitioners, and regulatory affairs professionals. The journal's open access digital components extend its reach to an international audience of pharmaceutical sciences professionals. While precise current circulation figures should be confirmed with the publisher, the readership profile is what matters most for advertisers: it is one of the most professionally concentrated HCP audience concentrations available through any single Indian print publication.

Q: Which premium ad positions are available in IJPS?

The premium ad positions in the Indian Journal of Pharmaceutical Sciences follow the standard hierarchy of print media advertising: the back cover ad is the most premium position, followed by the inside front cover, and then the inside back cover. Each of these positions offers a standalone visual presence that is not interrupted by editorial content on the facing page, which is a significant advantage for brand awareness and message retention. For brands planning conference promotion or product launches timed to major industry events, securing a premium position in the relevant issue is a strategy we recommend consistently, given the high overlap between IJPS readership and attendance at major pharmaceutical sciences conferences in India.

Q: Can I book an annual advertising package in IJPS?

Annual advertising packages in the Indian Journal of Pharmaceutical Sciences are available and, in our experience, represent the most cost-effective way to maintain a sustained presence in the journal. Because IJPS is a bi-monthly journal, an annual package covers all six issues of the year, which ensures continuous visibility among the journal's readership throughout the calendar year. Annual packages typically attract discounts of fifteen to thirty percent compared to single-insertion rates, and they also give advertisers the advantage of securing preferred positions — particularly premium positions like the back cover or inside front cover — for the full year before other advertisers can claim them.

Q: How long does it take to publish an ad in the Indian Journal of Pharmaceutical Sciences?

The lead time for publishing an advertisement in IJPS is typically four to six weeks from the copy deadline for each issue, which itself falls roughly four to six weeks before the publication date. In practical terms, this means that brands need to plan their IJPS advertising at least two to three months in advance of the issue they want to appear in — particularly for premium positions, which may be booked even earlier by advertisers who are planning annual campaigns. Working through a media agency that has an established relationship with the publication can sometimes help navigate tight timelines, though it is always better to plan ahead than to rely on last-minute accommodations.

Q: What is the ROI of advertising in Indian pharmaceutical journals?

The ROI of pharmaceutical journal advertising is best understood through a combination of brand tracking metrics and indirect business outcomes rather than direct response measurement. Brands that maintain a sustained presence in IJPS over multiple issues consistently report measurable improvements in brand awareness and preference among the journal's readership — improvements that translate into increased inbound enquiries, stronger consideration among procurement decision-makers, and improved brand perception scores among researchers and academics. The FICCI-EY Media and Entertainment Report and other industry data sources consistently show that print advertising in specialist professional publications delivers higher recall and purchase influence scores among professional audiences than equivalent digital spend, which supports the ROI case for pharmaceutical journal advertising in India.

Q: Are there third-party agencies that can help me book ads in IJPS at discounted rates?

Yes — working through a media buying agency is often the most practical and cost-effective route for booking ads in the Indian Journal of Pharmaceutical Sciences, particularly for brands that are running multi-publication campaigns or negotiating annual packages. Agencies like SmartAds.in, which operate across 500+ Indian cities and have established relationships with specialist publication publishers, can negotiate rates that are not available through direct booking and can manage the entire process from insertion order to artwork submission. This is especially valuable for brands that are new to pharmaceutical journal advertising and need guidance on format selection, position strategy, and timing relative to the IJPS editorial calendar.

Q: How does IJPS advertising compare to digital pharma marketing in India?

IJPS print advertising and digital pharma marketing serve different but complementary functions in a well-constructed pharmaceutical brand promotion strategy. IJPS advertising delivers credibility, deep reader engagement, and a sustained physical presence in the hands of highly qualified pharmaceutical sciences professionals; digital marketing delivers frequency, targeting precision, and real-time performance data. The most effective strategies we have seen use both in coordination: IJPS for authority and HCP audience quality, digital channels for retargeting and intent capture. For brands that are choosing between the two due to budget constraints, the decision should be driven by the target audience profile — if the primary target is researchers, academics, and senior pharmaceutical scientists, IJPS print advertising will typically deliver better ROI than an equivalent digital spend targeting the same group.

Q: What artwork specifications are required for IJPS magazine ads?

IJPS requires print-ready artwork submitted as high-resolution PDFs at a minimum of 300 DPI in CMYK colour mode. Bleed ads require a standard 3mm bleed on all sides, with all critical content — logos, text, key visual elements — kept within the safe zone to avoid trimming. Non-bleed ads should be sized precisely to the column dimensions specified in the current media kit. Fonts should be embedded or outlined to avoid substitution errors, and image files should be in CMYK rather than RGB to ensure accurate colour reproduction in print. We always recommend having artwork reviewed by a production professional before submission, as files that do not meet specifications can cause delays or quality issues that are difficult to correct once the printing process has begun.

Q: Is online or digital advertising available alongside print ads in IJPS?

The Indian Journal of Pharmaceutical Sciences has an online presence through its open access journal components and digital distribution, which creates opportunities for digital advertising alongside the print edition. The specific digital advertising options available — banner placements on the journal website, email newsletter sponsorships, or digital edition advertising — should be confirmed with the Indian Pharmaceutical Association at the time of booking, as these offerings evolve as the journal develops its digital infrastructure. For brands that want to combine the credibility of IJPS print advertising with the measurability of digital channels, a coordinated campaign that uses IJPS print for authority and the journal's digital platforms for frequency can be a particularly effective combination.

Planning Your IJPS Advertising Campaign: A Closing Note

The Indian Journal of Pharmaceutical Sciences occupies a genuinely unique position in the Indian pharmaceutical media landscape — it is the publication that the pharmaceutical sciences community has trusted for more than eight decades, which carries a weight of institutional credibility that no newer publication can match and no digital channel can replicate. For pharmaceutical companies India-wide, for research organisations, for laboratory equipment suppliers, for contract research and manufacturing organisations, and for any brand that needs to build authority and recognition among a highly qualified HCP audience, advertising in IJPS is not a niche tactic — it is a strategically sound investment in the most credible media environment available to them.

What we have seen consistently, across the campaigns our team has planned and executed in this space, is that the brands which treat IJPS advertising as a sustained commitment rather than a one-off experiment are the ones that see meaningful returns. A single insertion creates awareness; a sustained presence across multiple issues builds the kind of familiarity and trust that influences actual business decisions — procurement choices, research collaborations, formulation partnerships. The bi-monthly publication schedule gives advertisers a natural rhythm for campaign planning, and the combination of premium print positions with coordinated digital touchpoints creates a media mix that is genuinely difficult for competitors to replicate quickly.

The practical details — ad rates, format specifications, booking deadlines, artwork requirements — are all manageable, and they are all things that an experienced media planning team handles as a matter of routine. The more important decision is the strategic one: recognising that pharmaceutical journal advertising in India, and specifically advertising in the Indian Journal of Pharmaceutical Sciences, belongs in the media mix for any brand that is serious about reaching and influencing the pharmaceutical sciences professional community. If you are working through that decision and want a media partner who understands both the strategic case and the practical mechanics, the SmartAds.in team is available to help — we plan and execute IJPS advertising campaigns as part of integrated pharma media strategies across print, digital, and out-of-home channels, and we would be glad to build a customised media plan around your specific objectives and budget. You can reach us at SmartAds.in to start that conversation.